Neuraxis: Rosalind reports 9.9% stake subject to caps
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Neuraxis, Inc. (NRXS) is the subject of an amended beneficial-ownership report filed by Rosalind Advisors, Inc., Rosalind Master Fund L.P., Steven Salamon, the adviser’s president and portfolio manager, and Gil Aharon, its secretary and portfolio manager. Rosalind Advisors reported 2,788,563 common shares issuable upon full conversion and exercise of its reported securities; the fund reported 2,479,389 on the same basis. These figures do not give effect to conversion blockers, and actual beneficial ownership after applying them is lower.
Each reporting person’s cover page lists 9.9%, calculated using 14,193,209 common shares outstanding as of November 6, 2026. The Preferred Stock Blockers prevent conversion to the extent it would result in ownership above 9.99%. Rosalind Advisors, Steven Salamon, and Gil Aharon disclaim beneficial ownership of preferred stock held by the fund.
Key Figures
Key Terms
beneficial ownership regulatory
Preferred Stock Blockers technical
full conversion and exercise technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.